🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1/2, study evaluating IOV-2001 (Adoptive Cell Therapy) comp...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2020-02-19
Trial ID
NCT04155710
Treatments Being Tested
Chronic graft-versus-host disease (cGVHD) affects 30 to 70% of Allogeneic H...
Status
Unknown
Location
Hospital Universitario Dr. José Eleuterio González
Start Date
2022-04-01
Trial ID
NCT05348096
Treatments Being Tested
The purpose of this study is to assess the efficacy of ruxolitinib against ...
Status
Completed
Location
Incyte Investigative Site
Start Date
2017-06-29
Trial ID
NCT03112603
This Phase 3 multinational, randomized, double-blind study is designed to c...
Status
Completed
Location
The University of Arizona Cancer Centre-North Campus
Start Date
2017-06-19
Trial ID
NCT03112174
Treatments Being Tested
The goal of this observational study is to comprehensively profile six immu...
Status
Recruiting
Location
Radboud University Medical Center
Start Date
2025-07-29
Trial ID
NCT07021495
This phase I/II trial studies the side effects and best dose of laboratory ...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2013-05-22
Trial ID
NCT01865617
Treatments Being Tested
This is a Phase I/II interventional, open-label treatment study designed to...
Status
Recruiting
Location
Hematology/Oncology department
Start Date
2024-05-14
Trial ID
NCT06762431
Treatments Being Tested
To evaluate the safety and efficacy of ibrutinib in combination with predni...
Status
Completed
Location
Arizona Oncology - Scottsdale - Cancer Transplant Institute Location /ID# 1140-1120
Start Date
2017-05-11
Trial ID
NCT02959944
Treatments Being Tested
This is an open-label, multi-center Phase 1/2 study of oral LOXO-305 (pirto...
Status
Completed
Location
Mayo Clinic of Scottsdale
Start Date
2019-03-15
Trial ID
NCT03740529
Treatments Being Tested